Hoping our pooled data analysis is helpful to better understand long-term efficacy of acalabrutinib in higher-risk CLL Jeff Sharman Toby Eyre onclive.com/view/acalabrut… via @onclive

I highly encourage potential PhD students/postdocs to apply for a position to work with a brilliant and thoughtful PI Othman Al-Sawaf in an incredibly rich environment Uniklinik Köln

Thank you Michael Hallek for the honor of inviting me to present the update of this important trial, and for the great friendship and collaboration between our groups in service of pts with CLL.

Well done Christine Ryan, MD and the Dana-Farber Lymphoma team!

It was great to share the stage with you and learn from so many brilliant clinicians and scientists. Kudos to Charlie and the VJHemOnc team for the excellent organization of the mtg!

Exciting new tx option for pts with R/R CLL!

FDA Approves Lisocabtagene Maraleucel for R/R CLL or SLL onclive.com/view/fda-appro… via @onclive

I just committed to ride the Pan-Mass Challenge to support our research Dana-Farber. Click here to join me for #PMC2024 ! #OneInABillion secure.pmc.org/Ride #PMC2024 via @panmass

It was great working with you Othman Al-Sawaf on the commentary — hopefully our perspective on this important topic is helpful to others.

Honored to be recognized by ⁦The Leukemia & Lymphoma Society⁩ for our work ⁦Dana-Farber⁩ over the last few years to develop better therapies for patients with #CLL ! ⁦⁦Ross Levine⁩ lls.org/news/leukemia-…

FDA grants accelerated approval to pirtobrutinib for CLL/SLL — important new treatment option for patients fda.gov/drugs/resource…

Proud to support my friend Jason Westin, MD FACP for this position — he would be a highly valuable addition to the board for ASCO and its membership!

Please consider voting for Toni Choueiri, MD — a dynamic leader who will help to shape the future of cancer care!

It was an honor for us to host this incredible meeting attended by leading #CLL researchers from around the globe including Michael Hallek and many others.

Thank you Othman Al-Sawaf for your excellent talk at the mtg and the outstanding contributions of you, Michael Hallek and the entire GCLLSG to the field to benefit #CLL pts around the world!

Honored to contribute to the conversation, and I come away from this meeting with renewed energy and inspiration to continue to work toward cure for patients with CLL!

So proud of my colleague Cathy Wu from Dana-Farber for receiving the most prestigious award in the field of CLL research. Very well-deserved!

Getting everything ready for this afternoon’s poster session at #iwCLL2023

Our day is off to a strong start at #iwCLL . Our esteemed faculty panel of Dr. Nitin Jain (Nitin Jain), Dr. Othman Al-Sawaf (@Othman_Al_Sawaf), Dr. Kerry Rogers (of The James), Dr. Mazyar Shadman (@mshadman), and Dr. Matthew Davids (@DrMDavids) led a robust discussion and

⁦Inhye Ahn, MD⁩ from ⁦Dana-Farber⁩ presenting at #iwcll2023 on one of the largest datasets ever reported for BTKi resistance mechanisms in CLL ⁦⁦iwCLL⁩

Cathy Wu from ⁦Dana-Farber⁩ elegantly summarizing the current state of affairs in CLL proteomics #iwcll2023 ⁦iwCLL⁩